RaQualia Pharma Inc 4579.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
1,018.00quote price arrow down-21.00 (-2.02%)
Volume
150,800
52 week range
712.00 - 1,468.00

...

Loading . . .

KEY STATS

  • Open1,029.00
  • Day High1,038.00
  • Day Low1,012.00
  • Prev Close1,039.00
  • 52 Week High1,468.00
  • 52 Week High Date01/29/21
  • 52 Week Low712.00
  • 52 Week Low Date03/13/20
  • Market Cap214.71M
  • Shares Out20.95M
  • 10 Day Average Volume337,022.22
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-9.59

RATIOS/PROFITABILITY

  • EPS (TTM)16.40
  • P/E (TTM)62.07
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest RaQualia Pharma Inc News

There is no recent news for this security.

Latest 4579.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
RaQualia Pharma Inc. is a Japan-based company engaged in the research and development of pharmaceutical products. The Company is mainly engaged in the discovery and research, the preclinical trials and part of clinical trials of drugs, as well as the licensing of developed compounds to pharmaceutical companies. The Company is focused on pain diseases area and intestinal disease area. Its products include EP4 antagonist, cyclooxygenase-2 (COX-2) inhibitory, 5-HT4 portion...
Naoki Tani
President
Address
8F, Daiwa Meieki Bldg.
1-21-19, Meieki-Minami
Nakamura-ku
Nagoya-shi, ACH
450-0003
Japan